PPARɣ2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus
- 3 January 2022
- journal article
- research article
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 21 (1) , 241-250
Abstract
Purpose Diabetes mellitus (DM) is a growing global health concern. Genetic factors play a pivotal role in the development of diabetes. Therefore, the present work aimed to study the relation between peroxisome proliferator-activate receptors (PPARɣ2) (rs3856806), aldose reductase (AR) (rs759853), transcription factor 7 like 2 (TCF7L2) (rs7903146) gene polymorphism with diabetes in the Egyptian population. Methods The study included 260 diabetics and 120 healthy subjects. Genotyping was done using polymerase chain reaction-restriction fragment length polymorphism. Results Regression analysis revealed that PPARɣ2 TT, TCF7L2 TT were suggested to be independent risk predictors for T1DM and TCF7L2 TC, CC genotype were suggested to be independent protective factors against T1DM development. On the other hand, PPARɣ2 TT, AR TT genotypes were suggested to be independent risk predictors for T2DM susceptibility, and PPARɣ2 CT genotypes were suggested to be independent protective factors against T2DM development. Conclusion The present study revealed that PPARγ2 (rs3856806), TCF7L2 (rs7903146) and AR (rs759853) gene polymorphism may play an important role in the susceptibility of diabetes. Therefore, these polymorphisms may have a prognostic value for diabetes in the Egyptian population. Further work is required to confirm the role of these polymorphisms in diabetes.Keywords
This publication has 53 references indexed in Scilit:
- Role of peroxisome proliferator‐activated receptor gamma gene polymorphisms in type 2 diabetes mellitus patients of West Bengal, IndiaJournal of Diabetes Investigation, 2013
- The Association between Gene Polymorphism of TCF7L2 and Type 2 Diabetes in Chinese Han Population: A Meta-AnalysisPLOS ONE, 2013
- The meta-analysis of the association of PPARG P12A, C161T polymorphism and coronary heart diseaseWiener klinische Wochenschrift, 2012
- Distribution of peroxisome proliferator–activated receptor–gamma polymorphisms in Chinese and Dutch patients with inflammatory bowel diseaseInflammatory Bowel Diseases, 2010
- Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genesMolecular and Cellular Probes, 2009
- Predicting Type 2 Diabetes Based on Polymorphisms From Genome-Wide Association StudiesDiabetes, 2008
- Association of Peroxisome Proliferator-Activated Receptor.GAMMA. Gene Pro12Ala and C161T Polymorphisms With Metabolic SyndromeCirculation Journal, 2007
- Aldose reductase gene is associated with diabetic macroangiopathy in Japanese Type 2 diabetic patientsDiabetic Medicine, 2006
- Influence of the C161T but not Pro12Ala polymorphism in the peroxisome proliferator‐activated receptor‐gamma on colorectal cancer in an Indian populationCancer Science, 2005
- New less temperature-sensitive microchromatographic method for the separation and quantitation of glycosylated hemoglobins using a non-cyanide buffer systemJournal of Chromatography B: Biomedical Sciences and Applications, 1985